Pulmonary hypertension prevalence and significance in lung transplant recipients with cystic fibrosis and non-cystic fibrosis bronchiectasis

Key Points

• Pulmonary hypertension prevalence is notably high in lung transplant recipients with cystic fibrosis.
• The study specifically identifies a 40% prevalence of pulmonary hypertension among this population.
• Observational analysis across various lung clinics evaluates the significance of pulmonary hypertension in patients.
• These findings highlight the need for targeted monitoring and interventions for affected patients post-transplant.